Metropolitan Hospital once again confirms its active role in modern oncology developments by participating in the 8th Greek Oncology Congress, which will take place from May 6-9, 2026, in Thessaloniki, at the Makedonia Palace.
The Greek Oncology Congress is one of the most important scientific institutions for the country’s oncological community, bringing together doctors, health scientists, researchers and representatives from all specialties involved in daily cancer patient care.
Metropolitan Hospital at the 8th Greek oncology congress
The 8th Greek Oncology Congress (GOC) is organized by the scientific bodies of Medical Oncology and Radiation Oncology, with participation from other important scientific societies, including the Hellenic Society of Surgical Oncology, the Hellenic Society of Gynecological Oncology, the Hellenic Urological Association, the Hellenic Society of Pathological Anatomy, the Hellenic Endocrinological Society, and the Oncology Nursing Section of the National Association of Nurses of Greece. The organization demonstrates in practice that modern cancer treatment requires coordinated, multidisciplinary approaches.
During a period when knowledge, treatment options and technologies in oncology are evolving at a particularly rapid pace, Metropolitan Hospital actively supports scientific dialogue and multidisciplinary collaboration. Its participation in the 8th GOC reflects its steadfast commitment to implementing modern, evidence-based and personalized approaches in cancer diagnosis and treatment.
For Metropolitan Hospital, presence at the 8th Greek Oncology Congress is not merely participation in a scientific event. It represents expression of a consistent philosophy: that modern oncological care requires collaboration, technological advancement, clinical experience and genuine dedication to each patient’s needs.
Bringing together significant numbers of healthcare professionals from across the entire spectrum of oncological care, the 8th GOC constitutes an important field for exchanging knowledge, experience and scientific developments. In this context, Metropolitan Hospital continues to support progress in oncology and invest in practices that translate scientific evolution into substantial patient benefits.
At Metropolitan Hospital, member of the HHG Group, high-level oncological care remains a constant priority: with modern technologies, multidisciplinary approaches and human-centered care, alongside every person seeking effective medical support and better quality of life.
